| Financial Year |
March 31 2023 |
| Monetary Funds |
363,338,886.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
118,820,001.20 |
| Accounts Receivable |
114,213,865.20 |
| Advances to Suppliers |
12,207,030.30 |
| Other Receivables |
1,608,188.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
167,114,429.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,342,367.68 |
| Total Current Assets |
811,559,808.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
386,882,882.81 |
| Under-construction Projects |
39,214.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,523,371.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,338,078.68 |
| Other Non-Current Assets |
6,437,586.94 |
| Sub-Total of Non-Current Assets |
463,221,133.86 |
| Total Assets |
1,274,780,942.23 |
| Short-Term Loans |
500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
97,429,967.17 |
| Accounts Payable |
78,140,538.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,491,114.41 |
| Taxes Payable |
3,867,386.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,727,052.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,610,562.63 |
| Other Current Liabilities |
1,938,474.38 |
| Sub-Total of Current Liabilities |
228,295,860.91 |
| Long-term Loans |
500,000.00 |
| Bonds Payable |
223,011,703.35 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,044,722.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
246,646,371.92 |
| Total Liabilities |
474,942,232.83 |
| Paid-In Capital(Or Share Stock) |
130,021,212.00 |
| Capital Surplus |
188,508,808.37 |
| Surplus Reserve |
45,052,929.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
392,237,221.17 |
| Minority Stockholder's Interest |
1,882,648.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
797,956,060.75 |
| Owner's Equity（Stockholder's Equity） |
799,838,709.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,274,780,942.23 |
